Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
218
NCT02512588
A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2015
Completion: Feb 28, 2018
NCT03107013
A Study to Investigate the Mass Balance of BTD-001
Phase: Phase 1
Start: Apr 3, 2017
Completion: May 1, 2017
NCT03150498
A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001
Start: May 3, 2017
Completion: Jul 12, 2017
NCT03542851
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Start: May 29, 2018
Completion: May 28, 2020